Remove 2022 Remove Computational Chemistry Remove Trials
article thumbnail

Patent Highlights: Allosteric AR Modulators, Glycogen Synthase Inhibitors, and More

Drug Hunter

Oral Allosteric AR Modulator s request a trial You don’t have time to read everything, but you can’t afford to fall behind. Get ahead now by requesting a trial. Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples. already a member?

article thumbnail

How the AI revolution can accelerate early drug discovery

Drug Target Review

How AI/ML technology has accelerated drug discovery Although AI for drug discovery (AIDD) can be viewed as being in the initial phases of development and acceptance, compounds discovered using AIDD platforms are already entering clinical trials. Matthew subsequently put his computational chemistry skills to use in the defence sector.

Drugs 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sygnature Discovery accelerates global growth with major North American acquisition

Sygnature Discovery

Founded in 2011, NuChem Sciences delivers expert integrated and standalone discovery solutions across medicinal, synthetic, scale-up, process and computational chemistry, as well as DMPK, in vitro biology and in vivo pharmacology. Previous acquisitions made were Peak Proteins in April 2022 and SB Drug Discovery in January 2023.

article thumbnail

The Book of Nimbus

LifeSciVC

The premise at the time was that putting computational chemistry in the primary position for new molecule ideation would upend the drug discovery paradigm. set up a “virtual project team,” leverage Schrödinger scientists to lead computational chemistry, and do all the wet work at CROs. It did just that.